Indeed, when we knocked down ZIP7, a zinc transporter that is overexpressed in breast cancer, we observed similarly attenuated MDMX recovery in TPEN-treated MCF-7 cells upon adding back zinc (Fig. S7). Here, SLC39A7 is linked to breast carcinoma.